1
TÍTULO: Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study
AUTORES: Raffaele De Caterina; Peter Kelly; Pedro Monteiro; Jean Claude Deharo; Carlo de Asmundis; Esteban Lopez de Sa; Thomas W Weiss; Johannes Waltenberger; Jan Steffel; Joris R de Groot; Pierre Levy; Ameet Bakhai; Wolfgang Zierhut; Petra Laeis; Paul Egbert Reimitz; Paulus Kirchhof;
PUBLICAÇÃO: 2019, FONTE: JOURNAL OF CARDIOVASCULAR MEDICINE, VOLUME: 20, NÚMERO: 2
INDEXADO EM: Scopus WOS
2
TÍTULO: Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)  Full Text
AUTORES: Raffaele De Caterina; Peter Kelly; Pedro Monteiro; Jean Claude Deharo; Carlo de Asmundis; Esteban Lopez de Sa; Thomas W Weiss; Johannes Waltenberger; Jan Steffel; Joris R de Groot; Pierre Levy; Ameet Bakhai; Wolfgang Zierhut; Petra Laeis; Michael Kerschnitzki; Paul Egbert Reimitz; Paulus Kirchhof;
PUBLICAÇÃO: 2019, FONTE: BMC CARDIOVASCULAR DISORDERS, VOLUME: 19, NÚMERO: 1
INDEXADO EM: Scopus WOS
3
TÍTULO: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study  Full Text
AUTORES: Alexander T Cohen; Cihan Ay; Philippe Hainaut; Herve Decousus; Ulrich Hoffmann; Sean Gaine; Michiel Coppens; Pedro Marques da Silva; David J Jimenez Castro; Beatrice Amann Vesti; Bernd Brueggenjuergen; Pierre Levy; Julio L Lopez Bastida; Eric Vicaut; Petra Laeis; Eva Maria Fronk; Wolfgang Zierhut; Thomas Malzer; Peter Bramlage; Giancarlo Agnelli;
PUBLICAÇÃO: 2018, FONTE: THROMBOSIS JOURNAL, VOLUME: 16, NÚMERO: 1
INDEXADO EM: Scopus WOS